EXHIBIT 10.2 ------------ STOCK PURCHASE AGREEMENT THIS AGREEMENT is made on August 2, 2000 in the City of Montreal, Quebec. BETWEEN: METHYLGENE INC., a corporation incorporated under the laws of Canada (hereinafter referred to as the "Corporation")...Stock Purchase Agreement • August 11th, 2000 • Mgi Pharma Inc • Pharmaceutical preparations • Quebec
INDENTUREIndenture • March 4th, 2004 • Mgi Pharma Inc • Pharmaceutical preparations • New York
AND NORWEST BANK MINNESOTA, N. A., RIGHTS AGENTRights Agreement • July 15th, 1998 • Mgi Pharma Inc • Pharmaceutical preparations • Minnesota
Recitals --------License Agreement • May 5th, 2000 • Mgi Pharma Inc • Pharmaceutical preparations • Minnesota
AMENDMENT NO. 1 TO RIGHTS AGREEMENTRights Agreement • March 20th, 2000 • Mgi Pharma Inc • Pharmaceutical preparations
FORM OF COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • December 4th, 2002 • Mgi Pharma Inc • Pharmaceutical preparations • New York
Exhibit 4.1 MGI PHARMA, INC. (a Minnesota corporation) Senior Subordinated Convertible Notes due 2024 PURCHASE AGREEMENT Dated: February 25, 2004 TABLE OF CONTENTSPurchase Agreement • March 4th, 2004 • Mgi Pharma Inc • Pharmaceutical preparations • New York
ARTICLE 1 DEFINITIONSAsset Purchase Agreement • November 14th, 2000 • Mgi Pharma Inc • Pharmaceutical preparations • Maryland
Exhibit 10.25 MANUFACTURING AGREEMENT This Manufacturing Agreement (the "Agreement") is made and entered into effective as of December 12, 1995, by and between MGI PHARMA, INC., a Minnesota corporation ("MGI"), and GLOBAL PHARM INC., a corporation...Manufacturing Agreement • March 22nd, 1996 • Mgi Pharma Inc • Pharmaceutical preparations • Minnesota
RecitalsLicense Agreement • February 14th, 2001 • Mgi Pharma Inc • Pharmaceutical preparations • Minnesota
EXHIBIT 10.25 EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • March 30th, 1999 • Mgi Pharma Inc • Pharmaceutical preparations • California
EXHIBIT 10.31 ------------- LEASE AGREEMENT (Multi-Tenant Industrial) INDEX -----Lease Agreement • March 22nd, 2001 • Mgi Pharma Inc • Pharmaceutical preparations
This Agreement is made as of the 1st day of January, 1992, between MGI PHARMA, INC., a Minnesota corporation, with its principal offices at Suite 300E Opus Center, 9900 Bren Road East, Minnetonka, Minnesota 55343 (the "Company") and Lori-jean Gille...Termination Agreement • March 22nd, 1996 • Mgi Pharma Inc • Pharmaceutical preparations
FORM OF CONVERTIBLE SUBORDINATED PROMISSORY NOTEConvertible Subordinated Promissory Note • December 4th, 2002 • Mgi Pharma Inc • Pharmaceutical preparations • New York
ARTICLE 1 DEFINITIONSPromotion Agreement • May 14th, 1999 • Mgi Pharma Inc • Pharmaceutical preparations
ARTICLE 1 DEFINITIONSCo-Promotion Agreement • May 14th, 1999 • Mgi Pharma Inc • Pharmaceutical preparations
Exhibit 10.2 CONTROL AGREEMENT This CONTROL AGREEMENT (the "Agreement") dated as of March 2, 2004 by and among MGI Pharma, Inc. (the "Pledgor") and Wells Fargo Bank, National Association, in its capacity as trustee (the "Trustee"), and Wells Fargo...Control Agreement • March 4th, 2004 • Mgi Pharma Inc • Pharmaceutical preparations • New York
EXHIBIT 10.15 SEPARATION AGREEMENT AND MUTUAL RELEASE ------------------ This Separation Agreement and Mutual Release ("Separation Agreement") is made and entered into this 22nd day of October, 1996, by and between Rajesh C. Shrotriya, M.D....Separation Agreement • March 28th, 1997 • Mgi Pharma Inc • Pharmaceutical preparations • Minnesota
BACKGROUNDSupply and License Agreement • March 31st, 1998 • Mgi Pharma Inc • Pharmaceutical preparations
Exhibit 4.3 REGISTRATION RIGHTS AGREEMENT Dated March 2, 2004Registration Rights Agreement • March 4th, 2004 • Mgi Pharma Inc • Pharmaceutical preparations • New York
Exhibit 99.2 ------------ Supply and Purchase AgreementSupply and Purchase Agreement • April 25th, 2001 • Mgi Pharma Inc • Pharmaceutical preparations
TERMINATION AGREEMENTTermination Agreement • April 27th, 2006 • Mgi Pharma Inc • Pharmaceutical preparations
This Agreement is made as of the April 21, 2006, between MGI PHARMA, INC., a Minnesota corporation, with its principal offices at 5775 West Old Shakopee Road, Suite #100, Bloomington, Minnesota 55437 (the “Company”) and William F. Spengler (“Employee”), residing at 3812 Fenchurch Road, Baltimore, MD 21218.
EXHIBIT 1.1 ----------- COMMON STOCK UNDERWRITING AGREEMENTCommon Stock Underwriting Agreement • March 1st, 2001 • Mgi Pharma Inc • Pharmaceutical preparations • New York
Exhibit 10.1 PLEDGE AGREEMENT This PLEDGE AGREEMENT (the "Pledge Agreement") is made and entered into as of March 2, 2004 by MGI PHARMA, INC., a Minnesota corporation (the "Pledgor"), having its principal office at 5775 West Old Shakopee Road, Suite...Pledge Agreement • March 4th, 2004 • Mgi Pharma Inc • Pharmaceutical preparations • New York
EXHIBIT 10.1 ------------ STAND-BY PURCHASE AGREEMENTStand-by Purchase Agreement • March 1st, 2001 • Mgi Pharma Inc • Pharmaceutical preparations • New York
Exhibit 10.19 ------------- TERMINATION AGREEMENTTermination Agreement • March 24th, 2000 • Mgi Pharma Inc • Pharmaceutical preparations
Exhibit 10.15 TERMINATION AGREEMENTTermination Agreement • March 22nd, 1996 • Mgi Pharma Inc • Pharmaceutical preparations
CREDIT AGREEMENT dated as of October 18, 2006 among MGI PHARMA, INC., as a Borrower MGI GP, INC., as a Borrower MGI OM, INC., as a Borrower The Other Loan Parties The Lenders Party Hereto and JPMORGAN CHASE BANK, N.A., as Administrative Agent, Sole...Credit Agreement • October 24th, 2006 • Mgi Pharma Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT dated as of October 18, 2006 (as it may be amended or modified from time to time, this “Agreement”), among MGI PHARMA, INC., a Minnesota corporation, MGI GP, INC., a Delaware corporation, and MGI OM, INC., a Delaware corporation, as Borrowers, the other Loan Parties party thereto, the Lenders party hereto, and JPMORGAN CHASE BANK, N.A., as Administrative Agent.
Exhibit 10.29 ------------- TERMINATION AGREEMENT This Agreement is made as of the 16th day of January, 2001, between MGI PHARMA, INC., a Minnesota corporation, with its principal offices at 6300 West Old Shakopee Road, Suite #110, Bloomington,...Termination Agreement • March 29th, 2002 • Mgi Pharma Inc • Pharmaceutical preparations
LINE OF CREDIT AGREEMENTLine of Credit Agreement • July 22nd, 2005 • Mgi Pharma Inc • Pharmaceutical preparations • New York
Line of Credit Agreement (as amended or otherwise modified from time to time, this “Agreement”), dated as of July 20, 2005, is between GUILFORD PHARMACEUTICALS INC., a Delaware corporation (the “Borrower”), and MGI PHARMA, INC., a Minnesota corporation (the “Lender”).
December 14, 2007 Leon O. Moulder, Jr. Dear Leon:Retention Bonus Agreement • December 21st, 2007 • Mgi Pharma Inc • Pharmaceutical preparations
AGREEMENT AND PLAN OF MERGER by and among EISAI CO., LTD. JAGUAR ACQUISITION CORP. and MGI PHARMA, INC. Dated as of December 10, 2007Merger Agreement • December 11th, 2007 • Mgi Pharma Inc • Pharmaceutical preparations • New York
This AGREEMENT AND PLAN OF MERGER (this “Agreement”) is dated as of December 10, 2007, by and among Eisai Co., Ltd., a corporation organized under the laws of Japan (“Parent”), Jaguar Acquisition Corp., a Minnesota corporation and an indirect wholly-owned subsidiary of Parent (“Purchaser”), and MGI PHARMA, INC., a Minnesota corporation (the “Company”).
EXHIBIT 10.1 ------------ LICENSE, RESEARCH AND DEVELOPMENT AGREEMENT THIS LICENSE, RESEARCH AND DEVELOPMENT AGREEMENT is made as of August 2, 2000, by and between MGI PHARMA, INC., a Minnesota corporation having its principal place of business at...License, Research and Development Agreement • August 11th, 2000 • Mgi Pharma Inc • Pharmaceutical preparations • Minnesota
EXHIBIT 1.1 ----------- 1,000,000 Shares MGI PHARMA, INC. Common Stock, par value $0.01 per share FORM OF PLACEMENT AGENCY AGREEMENT ----------------------------------Placement Agency Agreement • May 18th, 2000 • Mgi Pharma Inc • Pharmaceutical preparations • Minnesota
MGI PHARMA, INC.Stock Option Agreement • November 14th, 2005 • Mgi Pharma Inc • Pharmaceutical preparations
This letter agreement (this “Agreement”) is being entered into by and between you and MGI PHARMA, INC. (the “Company”), a Minnesota corporation, in connection with certain stock options granted to you pursuant to the Company’s 1997 Stock Incentive Plan, the Guilford Pharmaceuticals, Inc. 2002 Stock Award and Incentive Plan (the “2002 Plan”) or 1999 Nonemployee Director Stock Option Plan that are “Underwater Options”, as defined below.
